Yuki Sakai

Yuki Sakai

Auto-generated profile, based on publicly available information

Yuki Sakai

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PBPremika S.W. Boedhoe
Premika S.W. Boedhoe
LSLianne Schmaal
Lianne Schmaal
YAYoshinari Abe
Yoshinari Abe
PAPino Alonso
Pino Alonso
SAStephanie H. Ameis
Stephanie H. Ameis
YWYsbrand Van Der Werf
Ysbrand Van Der Werf

1 March 2014 in American Journal of Psychiatry
Verified
Journal Article
Closed access
SWStella J. de Wit
Stella J. de Wit
PAPino Alonso
Pino Alonso
LSLizanne Schweren
Lizanne Schweren
DMDavid Mataix-Cols
David Mataix-Cols
CLChristine Lochner
Christine Lochner
OHOdile A. van Den Heuvel
Odile A. van Den Heuvel

18 April 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
AYAyumu Yamashita
Ayumu Yamashita
NYNoriaki Yahata
Noriaki Yahata
TITakashi Itahashi
Takashi Itahashi
GLGiuseppe Lisi
Giuseppe Lisi
TYTakashi Yamada
Takashi Yamada
HIHiroshi Imamizu
Hiroshi Imamizu
When collecting large amounts of neuroimaging data associated with psychiatric disorders, images must be acquired from multiple sites because of the limited capacity of a single site. However, site differences represent a barrier when acquiring multisite neuroimaging data. We utilized a traveling-subject dataset in conjunction with a multisite, multidisorder dataset to demonstrate that site differences are composed of biological sampling bias and engineering measurement bias. The effects on resting-state functional MRI connectivity based on pairwise correlations because of both bias types were greater than or equal to psychiatric disorder differences. Furthermore, our findings indicated that each site can sample only from a subpopulation of participants. This result suggests that it is essential to collect large amounts of neuroimaging data from as many sites as possible to appropriately estimate the distribution of the grand population. Finally, we developed a novel harmonization method that removed only the measurement bias by using a traveling-subject dataset and achieved the reduction of the measurement bias by 29% and improvement of the signal-to-noise ratios by 40%. Our results provide fundamental knowledge regarding site effects, which is important for future research using multisite, multidisorder resting-state functional MRI data. Recently, the importance of acquiring and sharing large amounts of resting-state functional magnetic resonance imaging (rs-fMRI) data from multiple geographical locations or sites has increased. However, differences in the data acquired from multiple sites create heterogeneities that present a barrier to the analysis. To properly manage these heterogeneous multisite data, it is important to have a deeper understanding of the origin of these between-site differences and to harmonize rs-fMRI data among sites. In this study, we demonstrate that site differences are composed of biological sampling bias (differences between the participant groups) and engineering measurement bias (differences in the properties of the MRI scanners used). We found that the effects of both types of bias on rs-fMRI functional connectivity were greater than or equal to those driven by psychiatric disorders. Furthermore, our results identified the specific properties of MRI scanners that affect the rs-fMRI connectivity. To overcome the limitations associated with site differences, we used a traveling-subject dataset, wherein multiple participants travel to multiple sites to assess measurement bias by controlling for participant effects between sites. Our results indicated that the traveling-subject dataset can help the proper harmonization of rs-fMRI data between sites.

16 June 2020 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PBPremika S.W. Boedhoe
Premika S.W. Boedhoe
DRDaan van Rooij
Daan van Rooij
MHMartine Hoogman
Martine Hoogman
JTJos W.R. Twisk
Jos W.R. Twisk
LSLianne Schmaal
Lianne Schmaal
OHOdile A. van Den Heuvel
Odile A. van Den Heuvel

1 October 2011 in European Psychiatry
Verified
Journal Article
Closed access
YSY. Sakai
Y. Sakai
JNJ. Narumoto
J. Narumoto
SNS. Nishida
S. Nishida
TNTakashi Nakamae
Takashi Nakamae
KYK. Yamada
K. Yamada
KFK. Fukui
K. Fukui
The basal ganglia represents a key component of the pathophysiological model for obsessive-compulsive disorder (OCD). This brain region is part of several neural circuits, including the orbitofronto-striatal circuit and dorsolateral prefronto-striatal circuit. There are, however, no published studies investigating those circuits at a network level in non-medicated patients with OCD. Resting state functional magnetic resonance imaging scans were obtained from 20 non-medicated patients with OCD and 23 matched healthy volunteers. Voxelwise statistical parametric maps testing strength of functional connectivity of three striatal seed regions of interest (ROIs) with remaining brain regions were calculated and compared between groups. We performed additional correlation analyses between strength of connectivity and the severity scores for obsessive-compulsive symptoms, depression, and anxiety in the OCD group. Positive functional connectivity with the ventral striatum was significantly increased (Pcorrected <.05) in the orbitofrontal cortex, ventral medial prefrontal cortex and dorsal lateral prefrontal cortex of subjects with OCD. There was no significant correlation between measures of symptom severity and the strength of connectivity (Puncorrected <.001). This is the first study to investigate the corticostriatal connectivity in non-medicated patients with OCD. These findings provide the first direct evidence supporting a pathophysiological model involving basal ganglia circuitry in OCD.

8 January 2019 in Frontiers in Neuroinformatics
Verified
Journal Article
Open access
PDF file
PBPremika S. W. Boedhoe
Premika S. W. Boedhoe
MHMartijn W. Heymans
Martijn W. Heymans
LSLianne Schmaal
Lianne Schmaal
YAYoshinari Abe
Yoshinari Abe
PAPino Alonso
Pino Alonso
JTJos Twisk
Jos Twisk
Objective: Brain imaging communities focusing on different diseases have increasingly started to collaborate and to pool data to perform well-powered meta- and mega-analyses. Some methodologists claim that a one-stage individual-participant data (IPD) mega-analysis can be superior to a two-stage aggregated data meta-analysis, since more detailed computations can be performed in a mega-analysis. Before definitive conclusions regarding the performance of either method can be drawn, it is necessary to critically evaluate the methodology of, and results obtained by, meta- and mega-analyses. Methods: Here, we compare the inverse variance weighted random-effect meta-analysis model with a multiple linear regression mega-analysis model, as well as with a linear mixed-effects random-intercept mega-analysis model, using data from 38 cohorts including 3,665 participants of the ENIGMA-OCD consortium. We assessed the effect sizes and standard errors, and the fit of the models, to evaluate the performance of the different methods. Results: The mega-analytical models showed lower standard errors and narrower confidence intervals than the meta-analysis. Similar standard errors and confidence intervals were found for the linear regression and linear mixed-effects random-intercept models. Moreover, the linear mixed-effects random-intercept models showed better fit indices compared to linear regression mega-analytical models. Conclusions: Our findings indicate that results obtained by meta- and mega-analysis differ, in favor of the latter. In multi-center studies with a moderate amount of variation between cohorts, a linear mixed-effects random-intercept mega-analytical framework appears to be the better approach to investigate structural neuroimaging data.